Ibex Medical Analytics

Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots

As of 1 September 2026, Ibex Medical Analytics's pricing is not published; the vendor quotes on request. Ibex runs AI over digitised biopsies as a first pass quality check before the pathologist signs out, and its differentiator is the number of laboratories running it in routine live service rather than in evaluation. Softwr lists it under Healthcare. Ibex Medical Analytics is made by Ibex Medical Analytics Ltd, available on Web, Self-hosted.

Visit siteVisit Ibex Medical Analytics

Overview

What Ibex Medical Analytics does

Ibex Medical Analytics is an Israeli company selling AI diagnostic support for anatomic pathology. Its clinical products are the Ibex Breast Suite, Ibex Prostate and Ibex Gastric, each analysing whole slide images to detect cancer and characterise features such as invasive carcinoma type, nuclear grading, Gleason grading and Helicobacter pylori. It runs either as a second read safety net after the pathologist or as a prescreening triage that highlights suspicious slides first, and it has extended the platform into biopharma biomarker work. The distinguishing point is deployment posture. Ibex has concentrated on getting algorithms into live routine clinical use in laboratories in Israel, the United Kingdom, the Nordics and the United States rather than accumulating pilots, and it publishes real world quality data from those deployments including cases where the AI flagged cancer that the reporting pathologist had missed. That evidence type, a running clinical safety net catching discrepancies in service, is a different and more persuasive argument than a retrospective reader study. It is also the reason the product is often justified as clinical governance spend rather than efficiency spend. Buyers are hospital histopathology departments and private laboratory groups, especially those under pressure from pathologist shortages. The trade offs are the same prerequisites as any pathology AI, a digitised laboratory, plus a sharper regulatory divide than buyers expect: the products carry CE marking under IVDR in Europe for defined diagnostic indications, while the United States position is narrower and some applications are used under laboratory developed test arrangements rather than FDA authorisation. That difference determines whether the algorithm can influence a signed out report or only serve as an internal quality check.

What people use it for

A histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign out
A private laboratory group standardising Gleason grading across pathologists with known interobserver variability
A service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its board
A gastrointestinal service wanting Helicobacter pylori detection automated so pathologists spend their time on the neoplastic cases

Where it falls short

Concrete and checkable, so you can decide whether any of them matter to you. This is the half of a review a vendor will not write about Ibex Medical Analytics.

The European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
It requires a fully digitised histopathology workflow, and slide scanning, storage and validation typically cost several times the algorithm licence.
Running it as a second read safety net adds a discrepancy resolution workload that departments consistently underestimate, and someone senior has to adjudicate every flag.
Coverage is limited to breast, prostate and gastric, so a general histopathology department still reads the majority of its case mix without any AI support.
Pricing is per case and unpublished, so cost scales directly with biopsy volume and does not flatten as the department grows.

Cross-shopped

What people choose instead of Ibex Medical Analytics

Each pairing was judged by two reviewers asking whether a buyer would genuinely weigh the two against each other. The ones that failed were deleted rather than published.

Ibex Medical Analyticsvs
Paige
Paige: If holding the first FDA De Novo authorisation for a pathology algorithm matters to your governance committee
Ibex Medical Analyticsvs
Sectra
Sectra: If the digital pathology workflow and archive is the gap rather than the algorithm
Ibex Medical Analyticsvs
LabWare
LabWare: If the underlying problem is laboratory information management rather than slide interpretation

Pricing

What Ibex Medical Analytics costs

Taken from the vendor's own pricing page. Prices move, so check before you buy.

Ibex clinical applications

On request

Priced per case analysed under an annual agreement
Breast, prostate and gastric licensed as separate suites
Regulatory indication differs between Europe and the United States
Deployment on premise or in cloud quoted per site

Capabilities

Features

Ibex Breast Suite
Detection and characterisation of invasive and in situ breast carcinoma with nuclear grading
Ibex Prostate
Cancer detection, Gleason grading and perineural invasion on prostate biopsies
Ibex Gastric
Detection of gastric cancer and Helicobacter pylori
Second read safety net
Runs after the pathologist and flags discrepancies before sign out
Prescreening triage
Reorders the slide queue so suspicious cases reach a pathologist first
Heatmap localisation
Highlights the tissue region driving each detection
Quality reporting
Tracks discrepancy rates between AI and reported diagnosis over time
Scanner-agnostic ingestion
Works across major whole slide scanner vendors rather than a single fleet

Answered, with sources

Questions people ask

Each answer names the page it came from, so you can check it rather than take our word for it.

Is Ibex FDA cleared?

The regulatory position differs by product and market. In Europe the products carry CE marking under IVDR for defined diagnostic indications; in the United States some applications are used under laboratory developed test arrangements. Confirm the exact status for the specific application and market before assuming it can influence a signed report.

Second read or prescreening?

Both are supported. Second read as a safety net is the more common clinical governance justification; prescreening is the efficiency case.

Does it need a particular scanner?

It ingests from the major whole slide scanner vendors rather than requiring a single fleet, which is a practical advantage over vendors tied to one scanner.

What tissue types are covered?

Breast, prostate and gastric. Everything else in the case mix is unsupported.

Keep looking

Where to go from Ibex Medical Analytics

Best Healthcare software for

Compare Ibex Medical Analytics with

Other Healthcare software

Paige
Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus
Pricing on request12 researched notes
Sectra
Enterprise imaging and PACS from a Swedish vendor that also sells the pathology and cardiology modules on one platform
Pricing on request12 researched notes
Techcyte
AI digital pathology across clinical, veterinary and environmental laboratory disciplines
Pricing on request11 researched notes
Annalise.ai
Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
Pricing on request12 researched notes
Gleamer
CE marked and FDA cleared imaging AI suite for bone trauma and chest, now owned by RadNet
Pricing on request12 researched notes
PathAI
Digital pathology image management with an FDA cleared platform for primary diagnosis
Pricing on request11 researched notes
Lunit
FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography
Pricing on request11 researched notes
Beckman Coulter DxONE
Clinical laboratory middleware and informatics from a diagnostics instrument manufacturer
Pricing on request11 researched notes
Ambra Health
Cloud medical image exchange and vendor neutral archive, now part of Intelerad
Pricing on request12 researched notes
Liberty Software
Pharmacy management software with a long record in independent retail
Pricing on request13 researched notes
OpenMRS
Open source electronic medical record platform for low-resource settings, with no vendor and paid implementers instead
Open source12 researched notes
Kareo Clinical
Specialized EHR and practice management for independent and small practices
From $89/mo12 researched notes
Practice Fusion
Free cloud-based EHR for medical practices
Free, then $199/mo8 researched notes
Ro
Telehealth platform for prescription services
From $39/mo8 researched notes
RXNT
Cloud practice management and EHR software with a la carte modules
10 researched notes
Signant Health
eCOA-first clinical trial platform that has grown outward into EDC, eConsent and televisits
Pricing on request9 researched notes
Sysmex
Haematology and urinalysis analysers sold with the middleware that decides which results a scientist ever sees
Pricing on request12 researched notes
Talkspace
Consumer online therapy and psychiatry app billed by subscription or insurance copay
9 researched notes

Softwr does not host reviews and shows no star rating for Ibex Medical Analytics, because a rating we did not collect is not ours to publish. What is here is the pricing and platform detail from the vendor’s own pages, limitations we could state concretely, and alternatives a reviewer confirmed people weigh against it. Tell us if any of it is wrong.

Best Healthcare software alternatives

View all Healthcare software